Common sleep supplement may be linked to lower risk of vision loss
The "sleep hormone" and common supplement melatonin could be linked to a decreased risk of age-related macular degeneration (AMD). AMD is a progressive eye condition affecting the macula, a small area near the centre of the retina, and can blur your central vision. There is no definitive cure for AMD but several treatments can help manage the condition and slow its progression. A team of researchers from the Case Western Reserve University School of Medicine and the Cole Eye Institute both based in the US looked at the health data of over 200,000 people, some at an early stage of the disease a...